Showing results (191-200 of 339) with videos related to
Sort By:
Pageof 34
Oncogene|December 22, 1999
Effects on normal fibroblasts and neuroblastoma cells of the activation of the p53 response by the nuclear export inhibitor leptomycin BP Smart, E B Lane, D P Lane, et al.Cancer Research|November 1, 1991
Expression of mutant p53 in melanomaJ R Stretch, K C Gatter, E Ralfkiaer, et al.The Journal of Biological Chemistry|December 25, 1988
Monoclonal antibodies to a proenkephalin A fusion peptide synthesized in Escherichia coli recognize novel proenkephalin A precursor formsB A Spruce, S Jackson, P J Lowry, et al.British Journal of Cancer|February 20, 2003
Nuclear export inhibitor leptomycin B induces the appearance of novel forms of human Mdm2 proteinS Menéndez, M Higgins, R G Berkson, et al.American Journal of Clinical Pathology|June 1, 1993
An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin's diseaseI A Doussis, F Pezzella, D P Lane, et al.Molecular and Cellular Biology|October 25, 2000
Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradationM S Rodriguez, J M Desterro, S Lain, et al.International Journal of Cancer|April 1, 1992
p53 expression and prognosis in gastric carcinomaH M Martin, M I Filipe, R W Morris, et al.The Journal of Cell Biology|July 24, 2002
Scotin, a novel p53-inducible proapoptotic protein located in the ER and the nuclear membraneJ-C Bourdon, J Renzing, P L Robertson, et al.The Journal of Pathology|January 1, 1992
A study of cell proliferation in formalin-fixed, wax-embedded bone marrow trephine biopsies using the monoclonal antibody PC10, reactive with proliferating cell nuclear antigen (PCNA)B S Wilkins, S Harris, N H Waseem, et al.The Journal of Pathology|May 1, 1995
Demonstration of DNA damage/repair in individual cells using in situ end labelling: association of p53 with sites of DNA damageP J Coates, V Save, B Ansari, et al.Pageof 34